NCT05767424

Brief Summary

Breast microcalcifications are a common mammographic finding. Microcalcifications are considered suspicious signs of breast cancer and a breast biopsy is required, however, cancer is diagnosed in only a few patients. Reducing unnecessary biopsies and rapid characterization of breast microcalcifications are unmet clinical needs. This study intends to implement a classification method for breast microcalcifications (as begnin or malign) with Artificial Intelligence techniques on mammographic images, evaluating the diagnostic performance (accuracy) of this approach. Another aim is the development of a diagnostic tool able to determining in-situ the biomolecular characteristics of microcalcifications. Raman spectroscopy (RS) is a highly specific method from the biomolecular point of view and it is able to explore molecular composition of a given sample through its direct irradiation (through laser light) and the simultaneous acquisition of emission signals. RS information could be combined togheter with imaging features to implement an AI model for the combined classification of breast microcalcifications

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,426

participants targeted

Target at P75+ for all trials

Timeline
27mo left

Started Jul 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Jul 2022Jul 2028

Study Start

First participant enrolled

July 22, 2022

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 14, 2023

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2025

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2028

Expected
Last Updated

August 27, 2025

Status Verified

July 1, 2025

Enrollment Period

3 years

First QC Date

March 2, 2023

Last Update Submit

August 25, 2025

Conditions

Keywords

Breast microcalcificationBreast cancerArtificial intelligence

Outcome Measures

Primary Outcomes (1)

  • Artificial Intellicence method for classification

    Classification method of breast microcalcifications with Artificial Intelligence techniques on mammography images

    36 months

Secondary Outcomes (2)

  • Radiological features extraction

    36 months

  • Artificial Intellicence method for combined classification

    36 months

Eligibility Criteria

Age18 Years - 88 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsBreast lesion is gender specif
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Breast patological patients who experience microcalcification lesion

You may qualify if:

  • Female subjects;
  • Age between 18 and 88 years;
  • Detection of microcalcifications on clinical and screening mammography with or without indication for histological assessment by biopsy;
  • Subjects who agree to participate in the study by signing and dating the Informed Consent form

You may not qualify if:

  • Personal history of breast cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istituti Clinici Scientifici Maugeri SpA

Pavia, Lombardy, 27100, Italy

Location

MeSH Terms

Conditions

Breast NeoplasmsCalcinosis

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesCalcium Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 2, 2023

First Posted

March 14, 2023

Study Start

July 22, 2022

Primary Completion

July 25, 2025

Study Completion (Estimated)

July 25, 2028

Last Updated

August 27, 2025

Record last verified: 2025-07

Locations